Analyst Reco. Evelo Biosciences, Inc.

Equities

EVLO

US2997342025

Market Closed - OTC Markets Other stock markets 07:00:00 30/04/2024 pm IST			5-day change	1st Jan Change
0.0495 ^USD	+18.14%		+16.47%	-19.51%

25/04	North American Morning Briefing : More Tech -2-	DJ
11/04	North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : More Tech -2-	25/04	DJ
TD Cowen Downgrades Evelo Biosciences to Market Perform From Outperform	18/23/18	MT
Morgan Stanley Adjusts Evelo Biosciences' Price Target to $10 From $2, Keeps Equalweight Rating	26/23/26	MT
Chardan Downgrades Evelo Biosciences to Neutral From Buy, Cuts Price Target to $2.50 From $5	16/22/16	MT
Morgan Stanley Adjusts Price Target on Evelo Biosciences to $4 From $5, Keeps Equalweight Rating	09/22/09	MT
Morgan Stanley Cuts Price Target on Evelo Biosciences to $4 From $5, Maintains Equalweight Rating	09/22/09	MT
Morgan Stanley Adjusts Evelo Biosciences' Price Target to $5 From $6, Maintains Equalweight Rating	24/22/24	MT
Chardan Research Adjusts Evelo Biosciences' Price Target to $5 From $12, Citing Dilution From Future Capital Raises, Maintains Buy Rating	15/22/15	MT
Cantor Fitzgerald Adjusts Price Target on Evelo Biosciences to $22 From $28, Reiterates Overweight Rating	25/22/25	MT
JMP Securities Adjusts Price Target on Evelo Biosciences to $41.50 From $44, Maintains Market Outperform Rating	02/21/02	MT
Chardan Upgrades Evelo Biosciences to Buy From Neutral on Valuation, Keeps $12 Price Target	01/21/01	MT
EVELO BIOSCIENCES : Morgan Stanley Adjusts Evelo Biosciences' Price Target to $9 from $13, Keeps Equalweight Rating	19/21/19	MT
EVELO BIOSCIENCES : Jefferies & Co Adjusts Evelo Biosciences PT to $14 From $18, Maintains Buy Rating	28/21/28	MT
EVELO BIOSCIENCES : Chardan Adjusts Price Target on Evelo Biosciences to $12 From $15, Maintains Neutral Rating	30/21/30	MT
EVELO BIOSCIENCES : JMP Securities Adjusts Evelo Biosciences' Price Target to $38 From $36, Maintains Market Outperform Rating	24/21/24	MT
EVELO BIOSCIENCES : Cantor Fitzgerald Initiates Coverage on Evelo Biosciences With Overweight Rating, $28 Price Target	23/21/23	MT
EVELO BIOSCIENCES : Morgan Stanley Adjusts Evelo Biosciences PT to $13 From $14, Maintains Equal Weight Rating	03/21/03	MT
EVELO BIOSCIENCES : Jefferies Upgrades Evelo Biosciences to Buy From Hold, Adjusts Price Target to $18 From $11	12/21/12	MT
EVELO BIOSCIENCES : Chardan Adjusts Price Target on Evelo Biosciences to $15 From $10, Maintains Neutral Rating	15/21/15	MT
EVELO BIOSCIENCES : JMP Securities Starts Evelo Biosciences at Market Outperform With $27 Price Target	23/20/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Evelo Biosciences, Inc.

Equities

EVLO

US2997342025

Analyst Reco.

Filters